Palantir (NASDAQ: PLTR) has been one of the stock market's biggest success stories over the last two years. Shares of the AI software company, which is best known for its work with government defense ...

Palantir Technologies Inc.'s 30% dip signals a buying opportunity amid growth in AI investments and defense spending. Click ...

NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framework, reigniting debate ...

The data analysis and surveillance company is the darling of Wall Street for its use of artificial intelligence in defense ...

Palantir shares tumbled Monday, extending losses over the past month. The artificial intelligence analytics company's stock has lost almost 40% of its value since closing at a record high on Feb ...

We are featuring all the reaction to the news of NHS England being scrapped and merged into the Department of Health and ...

NHS England – will be abolished in a bid to cut red tape and “free up” cash for front line services, Sir Keir Starmer has ...

In healthcare we trust—or do we? A breakdown in trust, like the schism in the transatlantic alliance, should make us think again about whether the current model requires reinvention. An anonymous ...

NHS chief data and analytics officers are worried about the way NHS England is running its Federated Data Platform programme.

There were few better stocks to own in 2024 than Palantir (NASDAQ: PLTR). It rose 341% in just a year, and 2025 hasn't been so bad, either. It has risen around 20% so far this year, but at the ...

Palantir does have a number of major clients in Europe, including the U.K.'s National Health Service (NHS), but the company's sluggish performance in Europe may reflect the reputational risk of ...

Palantir's growth has been soaring in the U.S., but the defense tech company's growth in Europe is plateauing. Its overseas struggles could exacerbate other risks for the stock. Shares of the AI ...